1044209-87-1

Basic information

• Product Name: tert-butyl 4-(3-methyl-5-nitrophenyl)piperazine-1-carboxylate
• Synonyms: tert-butyl 4-(3-methyl-5-nitrophenyl)piperazine-1-carboxylate
• CAS NO: 1044209-87-1
• Molecular Weight: 321.376
• Mol File: 1044209-87-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(3-methyl-5-nitrophenyl)piperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(3-methyl-5-nitrophenyl)piperazine-1-carboxylate(1044209-87-1)
• EPA Substance Registry System: tert-butyl 4-(3-methyl-5-nitrophenyl)piperazine-1-carboxylate(1044209-87-1)

Safety Data

• Hazardous Substances Data: 1044209-87-1(Hazardous Substances Data)

Upstream product

• 52488-28-5 1-bromo-3-methyl-5-nitrobenzene 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 

Downstream Products

• 1044209-89-3 tert-butyl 4-(3-amino-5-methylphenyl)piperazine-1-carboxylate 

Relevant articles and documents

TRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES

The invention relates to triazole compounds of formula I and I' or pharmaceutically acceptable salts thereof, useful as modulators of demyelinating diseases: The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention, methods of using the compositions and kits thereof in the treatment of various demyelinating and neurodegenerative diseases, including multiple sclerosis.

THERAMUTEIN MODULATORS

This invention relates to agents that are inhibitors or activators of variant forms of endogenous proteins and novel methods of identifying such variants. Of particular interest are inhibitors and activators of endogenous protein variants, encoded by genes which have mutated, which variants often arise or are at least first identified as having arisen following exposure to a chemical agent which is known to be an inhibitor or activator of the corresponding unmutated endogenous protein.